📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
33 announcements match the current filters (relevance ≥ 5).
Vaxtex Cotfab to Increase Capital to ₹500 Cr and Pivot to Renewable Energy & Food Sectors
Vaxtex Cotfab Limited (VCL) has announced a massive strategic pivot, proposing to increase its authorized share capital from ₹19 crore to ₹500 crore. The company plans to diversify beyond textiles into Renewable Energy (Solar, Wind, Green Hydrogen) and Agro-based food products. To facilitate this, the board approved increasing investment and borrowing limits to ₹500 crore and appointed a renewable energy expert, Mr. Dhiraj Mishra, as Executive Director. A name change is also proposed to reflect these new business activities, subject to shareholder approval at the EGM on February 27, 2026.
Key Highlights
Authorized share capital to be increased from ₹19 crore to ₹500 crore, a 26x increase
Strategic diversification into Renewable Energy, Green Hydrogen, and Agro-Food processing sectors
Investment and loan limits under Section 186 increased to ₹500 crore to support new ventures
Appointment of Mr. Dhiraj Mishra, who has experience in 750 MW+ solar projects, as Executive Director
Extraordinary General Meeting (EGM) scheduled for February 27, 2026, to seek shareholder approval
👀 What to Watch
Investors should monitor the EGM results and the subsequent fundraising methods, as the massive capital increase implies significant potential equity dilution. The radical shift in business model requires a cautious approach until clear execution milestones and project details are disclosed.
BVCL Proposes to Increase Authorized Share Capital from ₹25 Crore to ₹60 Crore
Barak Valley Cements Limited (BVCL) has issued a postal ballot notice to seek shareholder approval for more than doubling its authorized share capital. The proposal aims to increase the limit from ₹25 crore to ₹60 crore through the creation of 3.5 crore new equity shares of ₹10 each. This move is a necessary regulatory step that typically precedes future equity-based fundraising, such as a rights issue or preferential allotment. Shareholders can participate in the remote e-voting process from January 08 to February 07, 2026.
Key Highlights
Proposal to increase authorized share capital from ₹25,00,00,000 to ₹60,00,00,000.
Creation of an additional 3,50,00,000 equity shares with a face value of ₹10 each.
Consequent alteration required for Clause V of the Memorandum of Association (MoA).
Remote e-voting period scheduled from January 08, 2026, to February 07, 2026.
Final results of the postal ballot to be declared on or before February 10, 2026.
👀 What to Watch
Investors should watch for upcoming announcements regarding the specific purpose of this capital increase, as it likely signals an impending fundraise or corporate action. Monitor the company's debt levels and expansion plans to understand how the potential new capital might be utilized.
BVCL Board Approves Increase in Authorized Share Capital to ₹60 Crore from ₹25 Crore
Barak Valley Cements Limited (BVCL) has announced a significant increase in its authorized share capital from ₹25 crore to ₹60 crore. This change involves the creation of 3.5 crore additional equity shares with a face value of ₹10 each, bringing the total authorized equity shares to 6 crore. The board has also approved a postal ballot to seek shareholder approval for this amendment to the Memorandum of Association. Such a move is typically a precursor to future fund-raising activities like rights issues or preferential allotments.
Key Highlights
Authorized Share Capital increased by 140% from ₹25,00,00,000 to ₹60,00,00,000
Total number of authorized equity shares increased from 2.5 crore to 6 crore shares
Creation of 3.5 crore additional equity shares of ₹10 each approved
Board approved the draft Postal Ballot notice for seeking shareholder consent
Amendment to Clause V of the Memorandum of Association (MoA) proposed
👀 What to Watch
Investors should watch for upcoming announcements regarding specific fund-raising plans or expansion projects that this capital increase is intended to support. While this indicates growth potential, it also signals the possibility of future equity dilution.
BVCL Clarifies Credit Rating; Rejects CARE's BB+ Rating in Favor of CRISIL's BBB-
Barak Valley Cements Limited (BVCL) has formally contested a 'BB+ (Issuer Not Cooperating)' rating published by CARE Ratings, labeling it as misleading. The company states it had initiated a withdrawal of the rating engagement in July 2025 and provided all necessary documentation, including NOCs from its lenders. BVCL maintains that its current and valid credit rating is 'CRISIL BBB-' assigned by CRISIL Ratings Limited. This clarification suggests the CARE rating was a result of a procedural dispute rather than financial deterioration.
Key Highlights
BVCL requested withdrawal of CARE Ratings engagement on July 29, 2025, prior to the rating publication.
The company asserts its valid and final credit rating is 'CRISIL BBB-' from CRISIL Ratings.
NOCs were obtained from IDBI Bank for limits totaling ₹29.54 Cr and from NEDFi for a ₹16.00 Cr term loan.
BVCL submitted a 'No Default Statement' and all required banker/auditor details to CARE to facilitate the withdrawal.
The company advises stakeholders not to rely on the CARE BB+ rating for assessing its financial position.
👀 What to Watch
Investors should use the CRISIL BBB- rating as the primary benchmark for BVCL's creditworthiness. The dispute with CARE appears to be administrative, but investors should monitor if CARE issues a formal withdrawal notice.
Vaxtex Cotfab Announces Resignation of Two Independent Directors
Vaxtex Cotfab Limited has announced the simultaneous resignation of two Independent Directors, Mr. Harsh Mahendrakumar Kothari and Mr. Ravi Jitendra Modi, effective December 29, 2025. Both directors cited personal reasons and other professional commitments as the primary cause for their departure. The company confirmed that there are no other material reasons for these resignations. This change in the board structure will require the company to appoint new independent directors to remain compliant with SEBI corporate governance norms.
Key Highlights
Mr. Harsh Mahendrakumar Kothari (DIN: 09310696) resigned effective December 29, 2025.
Mr. Ravi Jitendra Modi (DIN: 10932249) resigned effective December 29, 2025.
Both directors confirmed no material reasons for resignation other than personal and professional commitments.
The resignations impact the composition of the Board and its various committees where the directors served.
The company is now tasked with filling these vacancies to meet regulatory requirements for independent board representation.
👀 What to Watch
Investors should monitor the company's upcoming board appointments to ensure they maintain the required number of independent directors. While the reasons cited are personal, simultaneous resignations of two independent directors warrant a cautious watch on corporate governance.
Vaxtex Cotfab Files for Reclassification of Four Promoters to Public Category
Vaxtex Cotfab Limited (VCL) has officially applied to the National Stock Exchange on December 26, 2025, for the reclassification of four promoter entities to the public category. The outgoing promoters include two individuals, Mr. Khushant Gupta and Mr. Mithleshkumar M Agrawal, and two corporate entities, Qmin Industries Limited and Vax Enterprise Private Limited. This move is being executed under Regulation 31A of SEBI (LODR) Regulations, 2015. Such reclassifications typically indicate a formal reduction in the influence or ownership stake of the founding group in the company's governance.
Key Highlights
Application for reclassification submitted to NSE on December 26, 2025
Four entities from the Promoter Group are seeking transition to the Public category
Outgoing individual promoters identified as Mr. Khushant Gupta and Mr. Mithleshkumar M Agrawal
Corporate entities Qmin Industries Limited and Vax Enterprise Private Limited are also seeking reclassification
The process follows compliance with Regulation 31A of SEBI (LODR) Regulations, 2015
👀 What to Watch
Investors should monitor the final approval from the stock exchange and observe if this change in promoter structure leads to any shifts in management or strategic direction. No immediate action is required as this is a regulatory filing regarding ownership status.
Vaxtex Cotfab Appoints 3 New Independent Directors and CS; 2 Directors Resign
Vaxtex Cotfab Limited (VCL) announced a major board restructuring on December 18, 2025, appointing three new Non-Executive Independent Directors and a new Company Secretary. These appointments follow the recent resignations of two independent directors, Ms. Hardika Ladha and Mr. Pranav Manoj Vajani, earlier in the week. The new appointees, including CS Rahul Mathur, bring over 7-8 years of experience in corporate governance and compliance. Furthermore, the board has authorized the sale of the company's investment units, which could impact the firm's liquidity or non-core asset holdings.
Key Highlights
Appointment of three new Non-Executive Independent Directors: Ms. Anjali Gupta, Mr. Puneet Kumar Kashyap, and Mr. Abhishek Sharma.
Resignation of two Independent Directors, Ms. Hardika Ladha and Mr. Pranav Manoj Vajani, effective mid-December 2025.
Appointment of Mr. Rahul Mathur as Company Secretary and Compliance Officer with 8+ years of experience.
Board approval for the sale of the company's investment units held in its name.
The board meeting was conducted within a 45-minute window from 3:30 P.M. to 4:15 P.M.
👀 What to Watch
Investors should monitor the company's strategic direction following this significant board reshuffle and the rationale behind the sale of investment units. Close attention should be paid to future governance disclosures to ensure stability after the high turnover of independent directors.
Vaxtex Cotfab Appoints 3 New Directors and CS, Approves Sale of Investment Units
Vaxtex Cotfab Limited announced a major overhaul of its board and management team on December 18, 2025. The company appointed three new Independent Directors and a new Company Secretary, Mr. Rahul Mathur, who brings over 8 years of experience. This follows the resignations of two existing Independent Directors earlier in the week. Furthermore, the board has authorized the sale of the company's investment units, which could impact the company's liquidity or non-core asset holdings.
Key Highlights
Appointed 3 new Independent Directors: Ms. Anjali Gupta, Mr. Puneet Kashyap, and Mr. Abhishek Sharma.
Appointed Mr. Rahul Mathur as Company Secretary and Compliance Officer with 8+ years of experience.
Noted the resignations of 2 Independent Directors, Ms. Hardika Ladha and Mr. Pranav Vajani.
Approved the sale of the company's investment in units held in the name of the company.
👀 What to Watch
Investors should monitor the company's governance transition and look for specific financial details regarding the sale of investment units.
Vaxtex Cotfab Announces Resignation of Independent Director and Chief Financial Officer
Vaxtex Cotfab Limited has reported the simultaneous resignation of two key officials effective December 16, 2025. Mr. Pranav Manoj Vajani has stepped down from his role as an Independent Director, citing pre-occupation with other professional commitments. Additionally, Mr. Pratapsingh Bhoorsingh Zala has resigned from the position of Chief Financial Officer (CFO) to pursue new career opportunities. The company must now seek replacements for these critical leadership and oversight roles.
Key Highlights
Mr. Pranav Manoj Vajani resigned as Independent Director effective from the close of business on December 16, 2025.
Mr. Pratapsingh Bhoorsingh Zala resigned as Chief Financial Officer (CFO) on the same date.
The CFO cited the pursuit of new career opportunities as the primary reason for his departure.
The Independent Director confirmed there are no material reasons for resignation other than professional pre-occupation.
Both officials were relieved of their duties as of the closure of working hours on December 16, 2025.
👀 What to Watch
Investors should exercise caution as the simultaneous exit of a CFO and a Board member can disrupt financial oversight. Monitor the company's upcoming filings for the appointment of a new CFO to ensure management stability.
Vaxtex Cotfab Announces Simultaneous Resignation of CFO and Independent Director
Vaxtex Cotfab Limited has reported the resignation of two key personnel, Mr. Pranav Manoj Vajani (Independent Director) and Mr. Pratapsingh Bhoorsingh Zala (Chief Financial Officer), effective December 16, 2025. Mr. Vajani cited pre-occupation with other professional assignments, while Mr. Zala is leaving to pursue new career opportunities. The simultaneous departure of a CFO and a board member often triggers scrutiny regarding internal stability. The company will need to appoint successors promptly to maintain regulatory compliance and financial oversight.
Key Highlights
Resignation of Chief Financial Officer Mr. Pratapsingh Bhoorsingh Zala effective Dec 16, 2025
Resignation of Independent Director Mr. Pranav Manoj Vajani effective Dec 16, 2025
Both officials confirmed no material reasons for resignation other than personal/professional commitments
Mr. Vajani holds directorships in 3 other listed entities including Shyamkamal Investments and 7nr Retail
Company must now fill the CFO vacancy to ensure continuity in financial reporting and compliance
👀 What to Watch
Investors should exercise caution and monitor the company's ability to quickly appoint a qualified CFO. The simultaneous exit of senior management and board members can sometimes indicate underlying administrative or operational shifts.
Vaxtex Cotfab CFO Pratapsingh Zala and Independent Director Pranav Vajani Resign
Vaxtex Cotfab Limited has announced the resignation of two key officials, Chief Financial Officer Mr. Pratapsingh Bhoorsingh Zala and Independent Director Mr. Pranav Manoj Vajani, effective December 16, 2025. The CFO cited the pursuit of new career opportunities, while the Independent Director mentioned pre-occupation with other professional assignments. Both individuals have confirmed there are no other material reasons for their departures. The company must now move to fill these vacancies to maintain corporate governance standards and financial oversight.
Key Highlights
CFO Pratapsingh Bhoorsingh Zala resigned effective from the close of business on December 16, 2025.
Independent Director Pranav Manoj Vajani also stepped down from the board on the same date.
Both resignations were attributed to personal reasons and other professional commitments.
The company has not yet announced successors for the Chief Financial Officer or the Independent Director positions.
👀 What to Watch
Investors should monitor the company for the appointment of a new CFO to ensure continuity in financial reporting and management. The simultaneous exit of a KMP and a director warrants a cautious watch on upcoming corporate governance disclosures.
Vaxtex Cotfab Appoints Amay Vatsalya as Whole-time Director; Devi Singh Resigns
Vaxtex Cotfab Limited (VCL) has announced the appointment of Mr. Amay Vatsalya as an Additional Director (Whole-time Director) for a five-year term effective December 5, 2025. Mr. Vatsalya brings over eight years of experience in international trade and exports, holding a Master's degree from the University of Westminster. Concurrently, Mr. Devi Singh has resigned from his position as Non-Executive Director to pursue other career opportunities. These changes are subject to shareholder approval at the upcoming Extra-Ordinary General Meeting.
Key Highlights
Mr. Amay Vatsalya appointed as Whole-time Director for a 5-year term until December 4, 2030.
New appointee has 8+ years of experience in international trade and global business development.
Mr. Devi Singh resigned as Non-Executive Director effective December 5, 2025, citing personal reasons.
The appointment is subject to regularization and approval by shareholders in the forthcoming EGM.
👀 What to Watch
Investors should monitor if the new director's expertise in international business leads to an expansion in the company's export portfolio. No immediate portfolio changes are recommended based on this routine management transition.
Vaxtex Cotfab Appoints Amay Vatsalya as Whole-Time Director; Devi Singh Resigns
Vaxtex Cotfab Limited has restructured its board by appointing Mr. Amay Vatsalya as an Additional Director (Whole-time Director) for a five-year term effective December 5, 2025. Mr. Vatsalya brings over eight years of experience in international trade and exports, which is expected to strengthen the company's global operations. Concurrently, Mr. Devi Singh has resigned from his role as a Non-Executive Director to pursue other career opportunities. These leadership changes are subject to shareholder approval at the upcoming Extra-Ordinary General Meeting.
Key Highlights
Appointment of Mr. Amay Vatsalya as Whole-time Director for a 5-year term until December 4, 2030.
Mr. Vatsalya possesses a Master’s in International Business Management and 8+ years of experience in global trade.
Resignation of Mr. Devi Singh from the position of Non-Executive Director effective December 5, 2025.
The board changes are pending final approval from shareholders in the forthcoming Extra-Ordinary General Meeting.
👀 What to Watch
Investors should monitor if the new director's expertise in international trade leads to improved export performance or strategic shifts in business operations. No immediate portfolio action is required based on these routine management changes.
